1988PubMedRequires access

Antigen test for early diagnosis of active cytomegalovirus infection in heart transplant recipients.

W. van der Bij, R B van Dijk, W. J. van Son, Ruurd Torensma, Kees B. Prenger, J Prop, A M Tegzess, T H The

Open publisher page 32 citations

Abstract

An assay was developed for the detection of cytomegalovirus (CMV) antigens in blood leukocytes and evaluated for its diagnostic significance in six heart transplant recipients. Slides of cytocentrifuged blood leukocytes were prepared at regular intervals during the posttransplantation period and stained with CMV-specific monoclonal antibodies, a procedure that took 3 hours. CMV-antigen-positive leukocytes were detected in all five patients with active CMV infection but not in the patient without CMV infection. These CMV-antigen-positive cells were transiently present and first detected 10 to 28 days before there was a significant increase in serum antibody levels. It is concluded that detection of CMV antigens in blood cells is a useful assay for the early diagnosis of active CMV infection in heart transplant recipients.

About this research paper

What this paper is about

An assay was developed for the detection of cytomegalovirus (CMV) antigens in blood leukocytes and evaluated for its diagnostic significance in six heart transplant recipients. Slides of cytocentrifuged blood leukocytes were prepared at regular intervals during the posttransplantation period and stained with CMV-specific monoclonal antibodies, a procedure that took 3 hours. CMV-antigen-positive leukocytes were detected in all five patients with active CMV infection but not in the patient without CMV infection. These CMV-antigen-positive cells were transiently present and first detected 10 to 28 days before there was a significant increase in serum antibody levels. It is concluded that detection of CMV antigens in blood cells is a useful assay for the early diagnosis of active CMV infection in heart transplant recipients.

Why it matters

OpenAlex reports 32 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

An assay was developed for the detection of cytomegalovirus (CMV) antigens in blood leukocytes and evaluated for its diagnostic significance in six heart transplant recipients. Slides of cytocentrifuged blood leukocytes were prepared at regular intervals during the posttransplantation period and stained with CMV-specific monoclonal antibodies, a procedure that took 3 hours. CMV-antigen-positive leukocytes were detected in all five patients with active CMV infection but not in the patient without CMV infection. These CMV-antigen-positive cells were transiently present and first detected 10 to 28 days before there was a significant increase in serum antibody levels. It is concluded that detection of CMV antigens in blood cells is a useful assay for the early diagnosis of active CMV infection in heart transplant recipients.

Key concepts: Cytomegalovirus, Medicine, Antigen, Betaherpesvirinae, Monoclonal antibody, Immunology, Herpesviridae, Antibody

Related papers

Back to paper searchBrowse research topicsOriginal source
Antigen test for early diagnosis of active cytomegalovirus infection in heart transplant recipients. — Research Paper | ScholarLens